Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2025-12-24 @ 11:44 PM
NCT ID:
NCT03026751
Eligibility Criteria:
Inclusion Criteria:
* Signed informed consent
* Patients \>= 18 years old
* Life expectancy more than 12 months
* Cytopenia defined as Hb \< 110g/L and/or Neutrophils \<1.5 x109/L and/or Platelets \<100 x109/L
Exclusion Criteria:
* Known haematological malignancy or aplastic anaemia/paroxysmal nocturnal haemoglobinuria
* Cytopenia of known aetiology (after examination of blood film and other investigations have occurred). These include haematinic deficiency (patients unresponsive to appropriate haematinic deficiency may enter the study), autoimmune cytopenias, chronic renal anaemia (for those with isolated anaemia), known haemoglobinopathy (for those with isolated anaemia), chronic viral diseases (Hep B/C/HIV), cytopenias associated with liver disease, cytopenias associated with systemic autoimmune conditions (eg SLE, rheumatoid arthritis), anaemia of chronic disease (for those with isolated anaemia).
* Cytotoxic chemotherapy or other myelosuppressive drugs or radiotherapy within 12 months
* Inadequate bone marrow sample for gene testing
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03026751
Study Brief:
Protocol Section:
NCT03026751